{
    "2018-12-04": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Incyte (INCY) Announces Positive Data on Jakafi for GVHD",
                "features": {
                    "keywords": [
                        "Incyte",
                        "Positive Data",
                        "Jakafi",
                        "GVHD"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "Ajovy Is a New Growth Driver for Teva Pharmaceutical",
                "features": {
                    "keywords": [
                        "Ajovy",
                        "Growth Driver",
                        "Teva Pharmaceutical"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "3 Big Pharma Stocks Hitting 52-Week Highs -- Are They Buys?",
                "features": {
                    "keywords": [
                        "Big Pharma Stocks",
                        "52-Week Highs",
                        "Buys"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-05",
                "original_text": "Bayer Is Just the Latest Pharma Giant to Get Back to Basics",
                "features": {
                    "keywords": [
                        "Bayer",
                        "Pharma Giant",
                        "Back to Basics"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}